These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2635837)

  • 21. Extraction of diethylhexylphthalate by home total parenteral nutrition from polyvinyl chloride infusion lines commonly used in the home.
    Loff S; Hannmann T; Subotic U; Reinecke FM; Wischmann H; Brade J
    J Pediatr Gastroenterol Nutr; 2008 Jul; 47(1):81-6. PubMed ID: 18607273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two methods of single-dose ampule opening and their influence upon glass particulate contamination.
    Giambrone AJ
    AANA J; 1991 Jun; 59(3):225-8. PubMed ID: 1950400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro analysis of overall particulate contamination exposure during multidrug IV therapy: impact of infusion sets.
    Perez M; Décaudin B; Abou Chahla W; Nelken B; Barthélémy C; Lebuffe G; Odou P
    Pediatr Blood Cancer; 2015 Jun; 62(6):1042-7. PubMed ID: 25755136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Particulate contamination from siliconized rubber stoppers--a statistical evaluation.
    Li LC; Parasrampuria J; Tian Y
    J Parenter Sci Technol; 1993; 47(5):270-3. PubMed ID: 8263665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Particles in intravenous solutions: a review.
    Thomas WH; Lee YK
    N Z Med J; 1974 Aug; 80(522):170-8. PubMed ID: 4608302
    [No Abstract]   [Full Text] [Related]  

  • 26. The potential hazard of particulate contamination of cardioplegic solutions.
    Robinson LA; Braimbridge MV; Hearse DJ
    J Thorac Cardiovasc Surg; 1984 Jan; 87(1):48-58. PubMed ID: 6690859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth of bacteria in intravenous fluids under stimulated actual-use conditions.
    Hugbo PG; Imhanlahimi WA
    Am J Hosp Pharm; 1983 Jun; 40(6):998-1001. PubMed ID: 6408922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pathological studies on pulmonary granulomas caused by aspiration of miso soup].
    Nagai K; Ihara K; Ito M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1973 Nov; 11(11):665-75. PubMed ID: 4798810
    [No Abstract]   [Full Text] [Related]  

  • 29. Cut-off fragments of rubber caps of bottles of contrast material: foreign bodies in the drip infusion system.
    Sakai O; Furuse M; Nakashima N
    AJNR Am J Neuroradiol; 1996; 17(6):1194-5. PubMed ID: 8791939
    [No Abstract]   [Full Text] [Related]  

  • 30. Particles in intravenous solutions. Microtechnique measurements.
    Thomas WH; Lee YK
    Acta Pharm Suec; 1974 Nov; 11(5):495-503. PubMed ID: 4440507
    [No Abstract]   [Full Text] [Related]  

  • 31. Quantitative analysis of inorganic particulate burden in situ in tissue sections.
    Abraham JL; Burnett BR
    Scan Electron Microsc; 1983; (Pt 2):681-96. PubMed ID: 6356333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of microfilters within the scope of infusion therapy].
    Böttiger BW; Bach A
    Infusionsther Transfusionsmed; 1994 Feb; 21(1):42-51. PubMed ID: 8173311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silting index determination--an alternative to particle counting for the control of particulate contamination in infusion fluids.
    Ernerot L
    Acta Pharm Suec; 1974 Feb; 11(1):15-24. PubMed ID: 4816412
    [No Abstract]   [Full Text] [Related]  

  • 34. The spontaneously hypertensive rat as a model of human cardiovascular disease: evidence of exacerbated cardiopulmonary injury and oxidative stress from inhaled emission particulate matter.
    Kodavanti UP; Schladweiler MC; Ledbetter AD; Watkinson WP; Campen MJ; Winsett DW; Richards JR; Crissman KM; Hatch GE; Costa DL
    Toxicol Appl Pharmacol; 2000 May; 164(3):250-63. PubMed ID: 10799335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. THE HARMFUL EFFECTS OF PARTICLES IN INTRAVENOUS FLUIDS.
    GARVAN JM; GUNNER BW
    Med J Aust; 1964 Jul; 2():1-6. PubMed ID: 14175312
    [No Abstract]   [Full Text] [Related]  

  • 36. [Particles in infusion solutions].
    Schmitz JE; Falk H
    Infusionsther Klin Ernahr; 1983 Oct; 10(5):250-3. PubMed ID: 6654493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
    Psathas PA; Kuzmission A; Ikeda K; Yasuo S
    Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Particulate matter in intravenous infusion fluids--phase 3.
    Turco SJ; Davis NM
    Am J Hosp Pharm; 1973 Jul; 30(7):611-3. PubMed ID: 4715106
    [No Abstract]   [Full Text] [Related]  

  • 39. Pulmonary disease due to aspiration of food and other particulate matter: a clinicopathologic study of 59 cases diagnosed on biopsy or resection specimens.
    Mukhopadhyay S; Katzenstein AL
    Am J Surg Pathol; 2007 May; 31(5):752-9. PubMed ID: 17460460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lung toxicity induced by intratracheal instillation of size-fractionated tire particles.
    Mantecca P; Sancini G; Moschini E; Farina F; Gualtieri M; Rohr A; Miserocchi G; Palestini P; Camatini M
    Toxicol Lett; 2009 Sep; 189(3):206-14. PubMed ID: 19501637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.